» Articles » PMID: 19812468

A Comparison Study of Mild Cognitive Impairment with 3 Memory Tests Among Chinese Individuals

Overview
Specialties Neurology
Psychiatry
Date 2009 Oct 9
PMID 19812468
Citations 98
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To examine whether 3 common memory tests differ statistically in terms of mild cognitive impairment (MCI) discrimination rates and conversion rates to Alzheimer disease.

Methods: A sample of 329 Chinese patients who consulted our memory clinic in Shanghai were tested using tasks including the auditory verbal learning test (AVLT), the logical memory (LM) test, the Rey-Osterrieth complex figure test, and other neuropsychologic tasks. One hundred and forty-nine of these patients were tested again using the identical tests 2 years later. The diagnose standard of probable Alzheimer disease is the same as the standard of the National Institute of Neurological and Communicative Diseases and Stroke-Alzheimer Disease and Related Disorders Association.

Results: The results of the MCI discrimination rates are as follows: AVLT-II (51%) >AVLT-I (31%) > complex figure test-II (27%) >LM-I (21%)=LM-II (21%) (I-immediate recall; II-delayed recall). The MCI group categorized based on LM-II cutoff has a higher conversion rate per year (24%), but also a higher reversal rate and missed diagnosis rate, whereas the group based on AVLT-II cutoff has a lower conversion rate per year (12%), but also a lower reversal rate and missed diagnosis rate.

Conclusions: The MCI discrimination rate and the conversion rate among different episodic memory tests are differ considerably.

Citing Articles

Connectome-based prediction of future episodic memory performance for individual amnestic mild cognitive impairment patients.

Zhang Z, Wang M, Lu T, Shi Y, Xie C, Ren Q Brain Commun. 2025; 7(1):fcaf033.

PMID: 39963290 PMC: 11831076. DOI: 10.1093/braincomms/fcaf033.


Multi-omics analyses identify gut microbiota-fecal metabolites-brain-cognition pathways in the Alzheimer's disease continuum.

Zhao H, Zhou X, Song Y, Zhao W, Sun Z, Zhu J Alzheimers Res Ther. 2025; 17(1):36.

PMID: 39893498 PMC: 11786436. DOI: 10.1186/s13195-025-01683-0.


Clinical characteristics and biomarker profile in early- and late-onset Alzheimer's disease: the Shanghai Memory Study.

Wu J, Wang J, Xiao Z, Lu J, Ma X, Zhou X Brain Commun. 2025; 7(1):fcaf015.

PMID: 39850631 PMC: 11756380. DOI: 10.1093/braincomms/fcaf015.


Genetic polymorphism in β-site amyloid precursor protein-cleaving enzyme 1 affects the structure of medial temporal lobe and cognition in Alzheimer's disease: an exploratory study.

Yin W, Li Z, Zheng W, Zhou X, Wan K, Tang Y Eur Arch Psychiatry Clin Neurosci. 2024; .

PMID: 39733191 DOI: 10.1007/s00406-024-01953-2.


Abnormal eye movements: relationship with clinical symptoms and predictive value for Alzheimer's disease.

Qi J, Lian T, Guo P, He M, Li J, Li J Front Aging Neurosci. 2024; 16:1471698.

PMID: 39640423 PMC: 11617582. DOI: 10.3389/fnagi.2024.1471698.